|
1
|
A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse.
|
Blood
|
2002
|
4.06
|
|
2
|
Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells.
|
Cardiovasc Res
|
2010
|
1.51
|
|
3
|
The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex.
|
J Biol Chem
|
2006
|
1.41
|
|
4
|
Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility.
|
J Biol Chem
|
2004
|
1.37
|
|
5
|
The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit.
|
J Biol Chem
|
2005
|
1.14
|
|
6
|
Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1).
|
J Biol Chem
|
2004
|
1.12
|
|
7
|
Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
|
Circ Res
|
2009
|
1.11
|
|
8
|
Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
|
Circ Res
|
2010
|
1.06
|
|
9
|
Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium.
|
J Biol Chem
|
2009
|
0.96
|
|
10
|
Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain.
|
J Biol Chem
|
2011
|
0.93
|
|
11
|
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
|
Circ Heart Fail
|
2013
|
0.91
|
|
12
|
Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps.
|
Sci China Life Sci
|
2011
|
0.89
|
|
13
|
Physiological implications of the interaction between the plasma membrane calcium pump and nNOS.
|
Pflugers Arch
|
2008
|
0.86
|
|
14
|
Plasma membrane calcium ATPase and its relationship to nitric oxide signaling in the heart.
|
Ann N Y Acad Sci
|
2007
|
0.84
|
|
15
|
Development and characterization of a novel fluorescent indicator protein PMCA4-GCaMP2 in cardiomyocytes.
|
J Mol Cell Cardiol
|
2013
|
0.83
|
|
16
|
Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells.
|
Carcinogenesis
|
2012
|
0.83
|
|
17
|
Calcium signaling dysfunction in heart disease.
|
Biofactors
|
2011
|
0.79
|
|
18
|
Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump--a novel therapeutic target for contraception and malaria.
|
J Pharm Pharm Sci
|
2013
|
0.77
|
|
19
|
Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.
|
Heart Fail Rev
|
2014
|
0.76
|
|
20
|
Measurement of plasma membrane calcium-calmodulin-dependent ATPase (PMCA) activity.
|
Methods Mol Biol
|
2010
|
0.75
|